Symbols

IVVD

Invivyd·NASDAQ

--(--)

Signals Analysis

Bullish signal 4

Bearish signal 1

Stock Price Surged Significantly

Consensus Rating "Strong Buy"

Ample Liquidity

High Gross Profit Margin

EPS Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About IVVD

Invivyd, Inc.

A biopharmaceutical company that develops antibodies to neutralize SARS-CoV-2, SARS-CoV-1, and pre-emergent coronaviruses

Industry

Pharmaceutical

Established Date

06/03/2020

Listing Date

08/06/2021

Exchange

NASDAQ Stock Exchange

Full-time Employees

122

Fiscal Year Ends

12-31

Website

www.invivyd.com

Security Type

Common stock

Office address

209 Church Street, New Haven, CT 06510

Business

Introduction

Invivyd, Inc., was incorporated in Delaware on June 3, 2020. The company is a commercial-stage company with a mission to rapidly and permanently deliver antibody-based therapies to protect vulnerable populations from the devastating consequences of the pandemic virus threat, starting with SARS-CoV-2. The company's proprietary INVYMAB platform approach combines state-of-the-art virus surveillance and predictive modeling with advanced antibody engineering. INVYMAB is designed to facilitate the rapid and continuous generation of new monoclonal antibodies (" MABs ") to keep pace with the evolving viral threat.

Company Financials

EPS

IVVD has released its 2025 Q4 earnings. EPS was reported at 0.02, versus the expected -0.09, beating expectations. The chart below visualizes how IVVD has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

IVVD has released its 2025 Q4 earnings report, with revenue of 17.21M, reflecting a YoY change of 24.51%, and net profit of -11.07M, showing a YoY change of 39.98%. The Sankey diagram below clearly presents IVVD's revenue sources and cost distribution.